MiniMed Group Statistics
Total Valuation
MiniMed Group has a market cap or net worth of $5.17 billion. The enterprise value is $4.93 billion.
| Market Cap | 5.17B |
| Enterprise Value | 4.93B |
Important Dates
The next confirmed earnings date is Tuesday, September 1, 2026, before market open.
| Earnings Date | Sep 1, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MiniMed Group has 280.84 million shares outstanding. The number of shares has increased by 1.50% in one year.
| Current Share Class | 280.84M |
| Shares Outstanding | 280.84M |
| Shares Change (YoY) | +1.50% |
| Shares Change (QoQ) | +6.05% |
| Owned by Insiders (%) | 0.19% |
| Owned by Institutions (%) | 12.54% |
| Float | 27.48M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 29.28 |
| PS Ratio | 1.67 |
| Forward PS | 1.51 |
| PB Ratio | 1.43 |
| P/TBV Ratio | 4.15 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.59 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.92, with a Debt / Equity ratio of 0.01.
| Current Ratio | 1.92 |
| Quick Ratio | 1.36 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -9.13% and return on invested capital (ROIC) is 2.16%.
| Return on Equity (ROE) | -9.13% |
| Return on Assets (ROA) | 1.73% |
| Return on Invested Capital (ROIC) | 2.16% |
| Return on Capital Employed (ROCE) | -4.84% |
| Weighted Average Cost of Capital (WACC) | n/a |
| Revenue Per Employee | $387,750 |
| Profits Per Employee | -$41,625 |
| Employee Count | 8,000 |
| Asset Turnover | 0.70 |
| Inventory Turnover | 4.09 |
Taxes
In the past 12 months, MiniMed Group has paid $128.00 million in taxes.
| Income Tax | 128.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
| Beta (5Y) | n/a |
| 52-Week Price Change | n/a |
| 50-Day Moving Average | 15.40 |
| 200-Day Moving Average | n/a |
| Relative Strength Index (RSI) | 65.20 |
| Average Volume (20 Days) | 1,158,256 |
Short Selling Information
The latest short interest is 6.35 million, so 2.26% of the outstanding shares have been sold short.
| Short Interest | 6.35M |
| Short Previous Month | 6.57M |
| Short % of Shares Out | 2.26% |
| Short % of Float | 23.09% |
| Short Ratio (days to cover) | 5.36 |
Income Statement
In the last 12 months, MiniMed Group had revenue of $3.10 billion and -$333.00 million in losses. Loss per share was -$1.30.
| Revenue | 3.10B |
| Gross Profit | 1.77B |
| Operating Income | 122.00M |
| Pretax Income | -189.00M |
| Net Income | -333.00M |
| EBITDA | -34.00M |
| EBIT | -190.00M |
| Loss Per Share | -$1.30 |
Balance Sheet
The company has $298.00 million in cash and $53.00 million in debt, with a net cash position of $245.00 million or $0.87 per share.
| Cash & Cash Equivalents | 298.00M |
| Total Debt | 53.00M |
| Net Cash | 245.00M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 3.61B |
| Book Value Per Share | 12.86 |
| Working Capital | 646.00M |
Cash Flow
In the last 12 months, operating cash flow was -$197.00 million and capital expenditures -$223.00 million, giving a free cash flow of -$420.00 million.
| Operating Cash Flow | -197.00M |
| Capital Expenditures | -223.00M |
| Depreciation & Amortization | 156.00M |
| Net Borrowing | n/a |
| Free Cash Flow | -420.00M |
| FCF Per Share | -$1.50 |
Margins
Gross margin is 57.06%, with operating and profit margins of 3.93% and -10.74%.
| Gross Margin | 57.06% |
| Operating Margin | 3.93% |
| Pretax Margin | -6.09% |
| Profit Margin | -10.74% |
| EBITDA Margin | -1.10% |
| EBIT Margin | -6.13% |
| FCF Margin | n/a |
Dividends & Yields
MiniMed Group does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -1.50% |
| Shareholder Yield | -1.50% |
| Earnings Yield | -6.44% |
| FCF Yield | -8.12% |
Analyst Forecast
The average price target for MiniMed Group is $21.00, which is 14.01% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $21.00 |
| Price Target Difference | 14.01% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | 9.42% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MiniMed Group has an Altman Z-Score of 3.41 and a Piotroski F-Score of 5.
| Altman Z-Score | 3.41 |
| Piotroski F-Score | 5 |